Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
青术颗粒治疗原发性急性痛风性关节炎(湿热瘀阻证)有效性与安全性的多中心、随机、双盲、安慰剂平行对照Ⅲ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy and safety of Qingzhu granules in the treatment of primary acute gouty arthritis (damp-heat and blood stasis syndrome)
确证青术颗粒治疗原发性急性痛风性关节炎(湿热瘀阻证)的有效性和安全性。
[Translation] To confirm the effectiveness and safety of Qingzhu Granule in the treatment of primary acute gouty arthritis (damp-heat and blood stasis syndrome).
100 Clinical Results associated with Beijing Tianshu Ruicao Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Tianshu Ruicao Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Tianshu Ruicao Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Tianshu Ruicao Pharmaceutical Technology Co., Ltd.